Skip to main content
. 2023 Mar 7;24(6):5089. doi: 10.3390/ijms24065089

Figure 2.

Figure 2

Systemic beneficial effects of SGLT2 inhibitors that contributes to cardiovascular and renal protection. AMPK, Adenosine Monophosphate Kinase; ATP, Adenosine Triphosphate; EPO, Erythrpoietin; NHE1, Sodium Hydrogen Exchange 1; PCT Proximal Convoluted Tubule; ROS, Reactive Oxygen Species; SGLT2i, Sodium Glucose Transporter 2 inhibitors; SIRT-1 Sirtuin 1; SNS, sympathetic nervous system; TGF, Tubuloglomerular Feedback.